| 25 May 2026 |
Anadrol (Oxymetholone) |
4.0 |
25mg |
31.0mg |
+24.0% |
99.14% |
Lab A |
| 25 May 2026 |
Vilon |
8.3 |
30mg |
29.7mg |
-1.0% |
95.64% |
Lab D |
| 24 May 2026 |
KPV Oral |
4.3 |
20mg |
18.0mg |
-10.2% |
99.02% |
Lab A |
| 24 May 2026 |
MGF |
9.7 |
20mg |
18.2mg |
-8.9% |
95.34% |
Lab F |
| 24 May 2026 |
L-Carnitine 500mg |
4.7 |
250mg/ml |
278.4mg/ml |
+11.4% |
96.53% |
Lab C |
| 24 May 2026 |
RIPEX 225 (TRA/Mast P/Test P) |
5.4 |
100mg/ml |
93.5mg/ml |
-6.5% |
97.07% |
Lab F |
| 24 May 2026 |
Selank |
4.0 |
50mg |
51.5mg |
+3.0% |
95.63% |
Lab C |
| 24 May 2026 |
Blend 300 (TRA/Mast P/Test P) |
4.9 |
200mg/ml |
236.7mg/ml |
+18.3% |
99.97% |
Lab C |
| 24 May 2026 |
NAD+ |
7.5 |
10mg |
9.6mg |
-4.3% |
98.50% |
Lab C |
| 23 May 2026 |
Ovagen |
4.7 |
10mg |
12.4mg |
+24.0% |
98.32% |
Lab F |
| 21 May 2026 |
Enclomiphene |
4.9 |
20mg |
17.1mg |
-14.3% |
98.83% |
Lab F |
| 21 May 2026 |
Ivermectin |
5.9 |
100mg |
119.1mg |
+19.1% |
98.22% |
Lab F |
| 21 May 2026 |
MT-1 |
9.6 |
50mg |
53.3mg |
+6.7% |
96.33% |
Lab E |
| 21 May 2026 |
NA Selank Amidate |
9.0 |
30mg |
31.0mg |
+3.5% |
95.22% |
Lab C |
| 21 May 2026 |
Semax |
4.3 |
10mg |
11.1mg |
+11.3% |
95.75% |
Lab B |
| 20 May 2026 |
Hyaluronic acid |
5.0 |
20mg |
24.4mg |
+21.9% |
96.04% |
Lab F |
| 20 May 2026 |
Pancragen |
4.4 |
50mg |
57.1mg |
+14.2% |
95.63% |
Lab A |
| 17 May 2026 |
Epithalon |
5.9 |
20mg |
21.3mg |
+6.4% |
95.68% |
Lab B |
| 29 Jan 2026 |
EPO |
5.2 |
20mg |
23.2mg |
+16.0% |
97.14% |
Lab B |
| 29 Jan 2026 |
GHRP-2 Acetate |
4.3 |
20mg |
19.7mg |
-1.7% |
98.17% |
Lab A |
| 26 Jan 2026 |
Retatrutide 30mg Pen Kit |
6.9 |
2mg |
2.1mg |
+7.2% |
95.79% |
Lab B |
| 26 Jan 2026 |
Test Suspension |
4.7 |
250mg/ml |
291.1mg/ml |
+16.4% |
95.05% |
Lab B |
| 9 Jan 2026 |
Boldenone Undecylenate (EQ) Raw |
5.4 |
10g |
10.9g |
+8.9% |
95.06% |
Lab A |
| 9 Jan 2026 |
Phenethyl bromide (2-bromoethylbenzene) CAS 103-63-9 |
5.5 |
10g |
12.5g |
+25.0% |
98.64% |
Lab E |
| 7 Jan 2026 |
Cerebrolysin |
4.0 |
15mg |
17.0mg |
+13.1% |
95.23% |
Lab B |
| 6 Jan 2026 |
LGD-4033 (Ligandrol) |
6.5 |
50mg |
44.3mg |
-11.4% |
98.20% |
Lab D |
| 6 Jan 2026 |
MOTS-C |
8.0 |
2mg |
2.0mg |
-1.6% |
98.79% |
Lab G |
| 29 Dec 2025 |
Dianabol |
7.5 |
10mg |
12.0mg |
+20.3% |
95.04% |
Lab E |
| 29 Dec 2025 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
6.3 |
2mg |
2.0mg |
+1.2% |
95.92% |
Lab A |
| 12 Dec 2025 |
Deca (Nandrolone Decanoate) |
4.0 |
200mg/ml |
172.3mg/ml |
-13.8% |
96.14% |
Lab D |
| 12 Dec 2025 |
Equipoise (Boldenone Undecylenate) |
6.6 |
250mg/ml |
271.3mg/ml |
+8.5% |
97.28% |
Lab F |
| 23 Nov 2025 |
Drostanolone Enanthate (Mast E) Raw |
5.8 |
100g |
118.9g |
+18.9% |
95.65% |
Lab B |
| 17 Nov 2025 |
Telmisartan |
4.0 |
25mg |
26.4mg |
+5.8% |
98.75% |
Lab G |
| 17 Oct 2025 |
NA Semax Amidate |
4.4 |
2mg |
2.4mg |
+21.7% |
98.48% |
Lab B |
| 17 Oct 2025 |
Testosterone Propionate Raw |
8.6 |
500g |
608.8g |
+21.8% |
96.79% |
Lab A |
| 9 Oct 2025 |
BPC157 5mg + TB500 5mg Blend |
9.1 |
2mg |
2.5mg |
+23.5% |
98.33% |
Lab D |
| 9 Oct 2025 |
Oxytocin Acetate |
7.7 |
50mg |
51.8mg |
+3.5% |
99.65% |
Lab F |
| 9 Oct 2025 |
P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 |
6.0 |
5g |
5.3g |
+7.0% |
99.65% |
Lab B |
| 24 Jul 2025 |
Tesamorelin |
5.8 |
5mg |
4.7mg |
-6.0% |
99.06% |
Lab A |